gefitero

Introduction to gefitero

Gefitero is a medication primarily used to treat a specific type of lung cancer known as non-small cell lung cancer (NSCLC). It is particularly effective for patients whose cancer cells have certain genetic mutations called EGFR mutations. Gefitero is often prescribed to patients who have not undergone chemotherapy before.

Composition of gefitero

The active ingredient in Gefitero is Gefitinib, which belongs to a class of drugs known as EGFR tyrosine kinase inhibitors. This means it works by blocking specific proteins that promote the growth of cancer cells.

Uses of gefitero

• Treatment of locally advanced NSCLC
• Treatment of metastatic NSCLC
• Specifically targets cancers with EGFR mutations

Side effects of gefitero

Common side effects:

• Diarrhea
• Skin rash
• Nausea
• Vomiting
• Loss of appetite

Serious side effects:

• Liver toxicity
• Lung inflammation
• Severe diarrhea leading to dehydration

Precautions of gefitero

Gefitero should not be used by individuals who do not have EGFR mutations. It is also not recommended for pregnant or breastfeeding women, those with severe liver or kidney disease, or individuals with a history of interstitial lung disease. If you are allergic to Gefitero or any of its ingredients, you should avoid this medication.

How to Take gefitero

• Take Gefitero orally, usually as a single tablet.
• The standard dose is 250 mg once daily.
• Try to take it at the same time each day for consistency.

Conclusion of gefitero

Gefitero is a targeted therapy for certain types of lung cancer, offering hope to patients with specific genetic profiles. While it can be highly effective, it is important to be aware of its side effects and take necessary precautions. Always consult with your healthcare provider to ensure it is the right treatment for you.